{"id":4734,"date":"2025-02-21T11:55:30","date_gmt":"2025-02-21T01:55:30","guid":{"rendered":"\/americas\/?p=4734"},"modified":"2026-03-03T15:51:00","modified_gmt":"2026-03-03T05:51:00","slug":"thailand-regulatory-application-for-remplir","status":"publish","type":"post","link":"\/americas\/thailand-regulatory-application-for-remplir\/","title":{"rendered":"Thailand Regulatory Application for Remplir\u2122"},"content":{"rendered":"<p>Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n<p>This is an important milestone in our global expansion plans for Remplir\u2122, with the Thailand nerve repair market representing an $84M opportunity.<\/p>\n<p>Remplir is now gaining record sales traction in Australia, New Zealand and Singapore, with all sights set on US FDA clearance in March\/April 2025.<\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC_ThailandRegulatoryApplication\">Click to read the ASX Release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has submitted a regulatory application to the FDA of Thailand to commence sales of its groundbreaking nerve repair device Remplir\u2122, with clearance expected in Q3 CY2025.<\/p>\n","protected":false},"author":2,"featured_media":4736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[21,2],"tags":[],"class_list":["post-4734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-asx-announcements","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/americas\/wp-json\/wp\/v2\/posts\/4734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/americas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/americas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/comments?post=4734"}],"version-history":[{"count":1,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4734\/revisions"}],"predecessor-version":[{"id":4735,"href":"\/americas\/wp-json\/wp\/v2\/posts\/4734\/revisions\/4735"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/media\/4736"}],"wp:attachment":[{"href":"\/americas\/wp-json\/wp\/v2\/media?parent=4734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/categories?post=4734"},{"taxonomy":"post_tag","embeddable":true,"href":"\/americas\/wp-json\/wp\/v2\/tags?post=4734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}